BioSpace News Archive

Akcea Therapeutics, Inc. announced that Damien McDevitt, chief executive officer, and Kyle Jenne, chief commercial officer, will participate in a fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference, which is being held virtually, on Tuesday, June 23, 2020 at 3:30 p.m. ET.

ReNeuron Group plc, a global leader in the development of cell-based therapeutics, provides the following update on its cell-based therapy programs.

The Cystic Fibrosis Foundation announced an investment of up to $14 million in 4D Molecular Therapeutics to develop a customized vehicle to deliver a healthy cystic fibrosis transmembrane conductance regulator gene into the lung cells of people with cystic fibrosis.

Abeona Therapeutics Inc., a fully-integrated leader in gene and cell therapy, announced Board of Director appointments that strengthen and expand the Company’s leadership.

Geisinger Wyoming Valley Medical Center is First in the World to Treat Patients with the New System

The UCSF Rosenman Institute is proud to announce the 2020 cohort of the Rosenman Innovators, a group of early-stage companies chosen for their innovative technologies and patient impact.

Continued evolution of EndoGastric Solutions’ EsophyX technology and concomitant use of TIF 2.0 with hiatal hernia repair brings long-term GERD relief to a broader spectrum of patients

Sysmex America, Inc. , a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, announced the availability of its XF-1600 ™ flow cytometer. The highly automated XF-1600 ™ provides laboratories with improved flex

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it is collaborating with Biomedical Advanced Research and Development Authority ( BARDA ), a component of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to further advance the de

The AARP-Howard University 1867 Health Innovations Project partnership will develop pilot technology projects for diabetes, hypertension, cardiovascular disease, genetic disorders, cancer, and neurodegenerative diseases.